Sudden Cardiac Death
0
Pipeline Programs
3
Companies
6
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ZollCA - San Jose
5 programsWearable Cardioverter DefibrillatorN/A1 trial
Wearable Cardioverter DefibrillatorN/A1 trial
Wearable Cardioverter DefibrillatorN/A1 trial
cardiac rehabilitationN/A1 trial
wearable defibrillatorN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Zollcardiac rehabilitation
ZollWearable Cardioverter Defibrillator
ZollWearable Cardioverter Defibrillator
ZollWearable Cardioverter Defibrillator
AbbottMagnet or Off-On
Zollwearable defibrillator
Clinical Trials (6)
Total enrollment: 2,036 patients across 6 trials
Cardiac Rehab Retrospective Review (CR3)
Start: Feb 2021Est. completion: Apr 202255 patients
N/ACompleted
Heart Failure Optimization Study
Start: Mar 2017Est. completion: Jun 2022602 patients
N/ACompleted
LifeVest Safety and Efficacy in Real Life Settings in France
Start: Feb 2017Est. completion: Mar 20191,164 patients
N/ACompleted
Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
Start: Jun 2015Est. completion: Dec 201766 patients
N/ATerminated
Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Implantable Cardioverter Defibrillators
Start: Dec 2011Est. completion: Oct 201380 patients
N/ACompleted
LifeVest Post-CABG Registry
Start: Feb 2011Est. completion: Oct 201469 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space